Related Experiment Videos

Congenital muscular dystrophies (CMD)

¹Dubowitz Neuromuscular Centre, Department of Paediatrics & Neonatal Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK. fmuntoni@imperial.ac.uk

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society

|September 27, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.

Neuromuscular disorders : NMD·2026

Respiratory management in spinal muscular atrophy: development of a global outcome measure.

Neuromuscular disorders : NMD·2025

Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review.

Neuromuscular disorders : NMD·2025

Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies.

Neuromuscular disorders : NMD·2025

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping.

Neuromuscular disorders : NMD·2023

A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs.

Neuromuscular disorders : NMD·2021

See all related articles